journal
MENU ▼
Read by QxMD icon Read
search

Netherlands Heart Journal

journal
https://www.readbyqxmd.com/read/29744816/periprocedural-anticoagulation-in-atrial-fibrillation-update-on-electrical-cardioversion-and-ablation
#1
REVIEW
S P G van Vugt, M A Brouwer
In this manuscript, we discuss the most important changes in the field of anticoagulant treatment in patients with atrial fibrillation in the setting of electrical cardioversion or catheter ablation. Moreover, we provide practical guidance as well as information on daily practice.
May 9, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29740755/optimal-antithrombotic-treatment-of-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention-triple-therapy-is-too-much
#2
REVIEW
M S Jacobs, R G Tieleman
Patients with atrial fibrillation who undergo a coronary intervention are eligible for both anticoagulation and (dual) antiplatelet therapy ((D)APT). An optimal balance has to be found to reduce the thromboembolic risk (i.e. stroke, systemic embolism and myocardial infarction) and to minimise the increased risk of bleeding with concomitant use of an anticoagulant and (D)APT. Owing to a lack of evidence, the guideline recommendations are predominantly based on expert opinion. Current evidence indicates that the combination of a non-vitamin K oral anticoagulant (NOAC) and clopidogrel is safer than vitamin-K oral antagonists plus DAPT, which increases the risk of bleeding, without clear advantages in regard to efficacy...
May 8, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29740754/a-practical-guide-on-how-to-handle-patients-with-bleeding-events-while-on-oral-antithrombotic-treatment
#3
REVIEW
M E Gimbel, S C S Minderhoud, J M Ten Berg
Bleeding is a feared complication in patients who are treated with antithrombotic therapy (oral anticoagulation or antiplatelet therapy). Management of antithrombotic therapy after bleeding poses a dilemma where restarting the crucial medication could lead to recurrent bleeding, while interrupting or even discontinuing treatment could increase the thrombotic risk. In this review, we provide recommendations regarding the treatment of patients with a bleeding event while on oral antithrombotic therapy, based on the literature and expert opinion...
May 8, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29722003/optimal-long-term-antithrombotic-management-of-atrial-fibrillation-life-cycle-management
#4
REVIEW
R Pisters, A Elvan, H J G M Crijns, M E W Hemels
Optimal antithrombotic management of atrial fibrillation equals balancing between prevention of arterial thromboembolism, predominantly ischaemic stroke, and haemorrhagic complications. Over time different antithrombotic agents and strategies have been developed. At present, non-vitamin K antagonist oral anticoagulants (NOACs) are the first-line therapy for stroke prevention in patients with non-valvular atrial fibrillation (i.e. without a mechanical valve prosthesis or rheumatic heart disease). Considering the impact of the suboptimal adoption of recommended oral anticoagulant therapy, as experienced with the previous first-line vitamin K antagonists, this review focuses on adequate use of NOACs...
May 2, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29713990/optimal-treatment-of-patients-with-nste-acs-in-the-dutch-health-care-system
#5
REVIEW
J P van Kuijk, J M Ten Berg
In the current daily practice of acute coronary syndromes, patients experiencing non-ST-elevation acute coronary syndrome (NSTE-ACS) represent the majority of this population. In these patients it is of utmost importance to estimate both ischaemic and bleeding risk, with subsequent, and preferably tailored pharmacological and, if indicated, invasive treatment. In this paper we describe the several risk scores and evaluate which are most applicable to the Dutch health-care system. Furthermore, we provide an overview of the recommended pharmacological treatment in keeping with the European Society of Cardiology guidelines...
April 30, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29713989/optimal-duration-of-dual-antiplatelet-therapy-for-coronary-artery-disease
#6
REVIEW
W J Kikkert, P Damman
The optimal duration of dual antiplatelet therapy (DAPT) for stable coronary artery disease and acute coronary syndrome is a complex decision. We review current literature on standard duration DAPT versus short duration DAPT (6 months or shorter) or extended duration DAPT (>12 months) after percutaneous coronary intervention with drug-eluting stent placement, and prolonged treatment after 12 months in acute coronary syndrome. Current guideline recommendations are summarised, including the use of risk scores for ischaemic and bleeding risk assessment...
April 30, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29687412/optimal-pharmacological-therapy-in-st-elevation-myocardial-infarction-a-review-a-review-of-antithrombotic-therapies-in-stemi
#7
REVIEW
R S Hermanides, S Kilic, A W J van 't Hof
Antithrombotic therapy is an essential component in the optimisation of clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. There are currently several intravenous anticoagulant drugs available for primary percutaneous coronary intervention. Dual antiplatelet therapy comprising aspirin and P2Y12 inhibitor represents the cornerstone treatment for STEMI. However, these effective treatment strategies may be associated with bleeding complications...
April 23, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29667076/cough-up-your-lungs
#8
L A J Rammeloo, N A Blom
No abstract text is available yet for this article.
April 17, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29667075/cough-up-your-lungs
#9
L A J Rammeloo, N A Blom
No abstract text is available yet for this article.
April 17, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29654515/five-year-clinical-follow-up-of-the-stentys-self-apposing-stent-in-complex-coronary-anatomy-a-single-centre-experience-with-report-of-specific-angiographic-indications
#10
H Lu, R J Bekker, M J Grundeken, P Woudstra, J J Wykrzykowska, J G P Tijssen, R J de Winter, K T Koch
OBJECTIVES: We sought to investigate angiographic indications for the use of the STENTYS technique and evaluated the long-term safety and clinical efficacy of the stent. BACKGROUND: Coronary lesions involving complex anatomy, including aneurysmatic, ectatic, or tapered vessel segments often carry a substantial risk of stent malapposition. The self-apposing stent technique may reduce the risk of stent malapposition and therefore improve clinical outcomes. METHODS: A total of 120 consecutive patients treated with the STENTYS stent were included (drug-eluting stent (DES) n = 101, bare-metal stent (BMS) n = 19)...
April 13, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29644502/healing-in-the-colourful-helius-experience
#11
EDITORIAL
R Delewi, J J Piek
No abstract text is available yet for this article.
April 11, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29644501/ethnic-disparities-in-estimated-cardiovascular-disease-risk-in-amsterdam-the-netherlands-the-helius-study
#12
W Perini, M B Snijder, R J G Peters, A E Kunst
BACKGROUND: Ethnic differences have been reported in cardiovascular disease (CVD) risk factors. It is still unclear which ethnic groups are most at risk for CVD when all traditional CVD risk factors are considered together as overall risk. OBJECTIVES: To examine ethnic differences in overall estimated CVD risk and the risk factors that contribute to these differences. DESIGN: Using data of the multi-ethnic HELIUS study (HEalthy LIfe in an Urban Setting) from Amsterdam, we examined whether estimated CVD risk and risk factors among those eligible for CVD risk estimation differed between participants of Dutch, South Asian Surinamese, African Surinamese, Ghanaian, Turkish and Moroccan origin...
April 11, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29637477/real-world-management-of-heart-failure-in-the-netherlands-improving-quality-of-care-by-simple-measures
#13
EDITORIAL
S Koudstaal, F W Asselbergs
No abstract text is available yet for this article.
April 10, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29619672/resuscitation-on-the-pitch-with-cardiac-massage-and-on-site-aed
#14
LETTER
N M Panhuyzen-Goedkoop, J J Piek
No abstract text is available yet for this article.
April 4, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29572763/nvvc-nhj-durrer-prizes-2017
#15
EDITORIAL
J J Piek
No abstract text is available yet for this article.
March 23, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29564639/real-world-heart-failure-management-in-10-910-patients-with-chronic-heart-failure-in-the-netherlands-design-and-rationale-of-the-chronic-heart-failure-esc-guideline-based-cardiology-practice-quality-project-check-hf-registry
#16
J J Brugts, G C M Linssen, A W Hoes, H P Brunner-La Rocca
AIMS: Data from patient registries give insight into the management of patients with heart failure (HF), but actual data from unselected real-world HF patients are scarce. Therefore, we performed a cross sectional study of current HF care in the period 2013-2016 among more than 10,000 unselected HF patients at HF outpatient clinics in the Netherlands. METHODS: In 34 participating centres, all 10,910 patients with chronic HF treated at cardiology centres were included in the CHECK-HF registry...
March 21, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29532365/inappropriate-shock-caused-by-p-wave-oversensing-in-an-entirely-subcutaneous-icd
#17
B A Mulder, A H Maass, Y Blaauw
No abstract text is available yet for this article.
March 12, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29541996/short-versus-long-duration-of-dual-antiplatelet-therapy-following-drug-eluting-stents-a-meta-analysis-of-randomised-trials
#18
R Rozemeijer, M Voskuil, J P Greving, M L Bots, P A Doevendans, P R Stella
BACKGROUND: Dual antiplatelet therapy (DAPT) remains the cornerstone therapy in the prevention of ischaemic events following drug-eluting stent (DES) implantation. Mandatory duration of DAPT after DES however, is a matter of debate. We aimed to evaluate safety and efficacy of short-term (up to 6 months) versus long-term (12 months) DAPT after DES implantation. METHODS: We searched PubMed, EMBASE, Cochrane databases, and international meetings for randomised clinical trials (RCTs) comparing short with long DAPT...
May 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29532366/atrial-fibrillation-mimicking-ventricular-fibrillation-confuses-an-automated-external-defibrillator
#19
M Hulleman, M T Blom, A Bardai, H L Tan, R W Koster
No abstract text is available yet for this article.
May 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29520622/resuscitating-athletes
#20
LETTER
P Calle
No abstract text is available yet for this article.
May 2018: Netherlands Heart Journal
journal
journal
39609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"